Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Malm

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|October 9, 2012
Prenatal exposure to selective serotonin reuptake inhibitors and infant outcomeHeli Malm
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
Which drugs can be used during pregnancy?Heli Malm, Maria Ellfolk
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2012
[Poisonings and their treatment during pregnancy]Maria Ellfolk, Heli Malm
Reproductive Toxicology (Elmsford, N.Y.)|May 8, 2010
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)Maria Ellfolk, Heli Malm
Duodecim; Laaketieteellinen Aikakauskirja|August 22, 2013
[Multiple sclerosis and pregnancy]Jori Ruuskanen, Heli Malm, Laura Airas
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2016
Dr. Malm et al. replyHeli Malm, Alan S Brown, André Sourander
JAMA Psychiatry|March 16, 2017
Serotonin Reuptake Inhibitor Use During Pregnancy-ReplyAlan S Brown, Heli Malm, Andre Sourander
Obstetrics and Gynecology|December 2, 2005
Risks associated with selective serotonin reuptake inhibitors in pregnancyHeli Malm, Timo Klaukka, Pertti J Neuvonen
Drug Safety|April 26, 2013
Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in FinlandMiia Artama, Mika Gissler, Heli Malm, et al.
American Journal of Obstetrics & Gynecology MFM|May 6, 2026
Authors reply to letter to the editor regarding "Selective serotonin reuptake inhibitor use during pregnancy and maternal depression: a nationwide birth cohort study on risks to the mother and the newborn"Heli Malm, Keely Cheslack-Postava, Ian W McKeague
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|October 9, 2012
Prenatal exposure to selective serotonin reuptake inhibitors and infant outcomeHeli Malm
Duodecim; Laaketieteellinen Aikakauskirja|December 1, 2017
Which drugs can be used during pregnancy?Heli Malm, Maria Ellfolk
Duodecim; Laaketieteellinen Aikakauskirja|November 22, 2012
[Poisonings and their treatment during pregnancy]Maria Ellfolk, Heli Malm
Reproductive Toxicology (Elmsford, N.Y.)|May 8, 2010
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)Maria Ellfolk, Heli Malm
Duodecim; Laaketieteellinen Aikakauskirja|August 22, 2013
[Multiple sclerosis and pregnancy]Jori Ruuskanen, Heli Malm, Laura Airas
Journal of the American Academy of Child and Adolescent Psychiatry|July 26, 2016
Dr. Malm et al. replyHeli Malm, Alan S Brown, André Sourander
JAMA Psychiatry|March 16, 2017
Serotonin Reuptake Inhibitor Use During Pregnancy-ReplyAlan S Brown, Heli Malm, Andre Sourander
Obstetrics and Gynecology|December 2, 2005
Risks associated with selective serotonin reuptake inhibitors in pregnancyHeli Malm, Timo Klaukka, Pertti J Neuvonen
Drug Safety|April 26, 2013
Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in FinlandMiia Artama, Mika Gissler, Heli Malm, et al.
American Journal of Obstetrics & Gynecology MFM|May 6, 2026
Authors reply to letter to the editor regarding "Selective serotonin reuptake inhibitor use during pregnancy and maternal depression: a nationwide birth cohort study on risks to the mother and the newborn"Heli Malm, Keely Cheslack-Postava, Ian W McKeague
Pageof 5